Back to results
Not yet recruitingPhase 3

Masitinib in Patients With Mild Alzheimer's Disease

NCT05564169

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universitaires Pitié-Salpêtrière

Paris, France

+8 additional locations

Contact

Clinical Study Coordinator

+33(0)147200014clinical@ab-science.com
View on ClinicalTrials.gov
Masitinib in Patients With Mild Alzheimer's Disease — TrialFind